MyFinsight
Home
About
Contact
abcl: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, ABCL has $1,355,992K in assets.
Balance Sheets Overview
00
No enough data to generate the overview
Subscribe for Financial Insights
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Total assets
1,355,992
1,402,061
Total shareholders' equity
964,038
1,007,076
Total liabilities and shareholders' equity
1,355,992
1,402,061
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Page 1
Buy me a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Gross carrying amount
$91,133K
Marketable securities
$412,513K
Cash and cash
equivalents
$83,159K
Other long-term
assets
$53,066K
Investments in equity
accounted investees
$93,301K
Goodwill
$47,806K
Intangible assets, net
$39,321K
Property and equipment,
net
$427,358K
Other current assets
$133,012K
Restricted cash
$25,000K
Accounts and accrued
receivable
$41,456K
Total cash, cash
equivalents, and marketable...
$495,672K
Accumulated amortization
$51,812K
Total long-term
assets
$660,852K
Total current assets
$695,140K
Total assets
$1,355,992K
Total liabilities and
shareholders' equity
$1,355,992K
Total shareholders'
equity
$964,038K
Total liabilities
$391,954K
Accumulated earnings
(deficit)
-$20,537K
Accumulated other
comprehensive loss
-$2,698K
Additional paid-in capital
$192,804K
Common shares no par
value, unlimited...
$794,469K
Total long-term
liabilities
$323,150K
Total current
liabilities
$68,804K
Other long-term
liabilities
$1,386K
Deferred tax liability
$9,744K
Deferred government
contributions
$169,118K
Deferred revenue
$5,850K
Operating lease liability
$137,052K
Deferred revenue
$15,687K
Accounts payable and
other current...
$53,117K
Buy me a coffee
AbCellera Biologics Inc. (ABCL)
AbCellera Biologics Inc. (ABCL)